During the past decade, Wilhelminenspital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 26 clinical trials were completed, i.e. on average, 89.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 15 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilhelminenspital" #1 sponsor was "Gilead Sciences" with 7 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Medical University of Vienna" with 5 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilhelminenspital" #1 collaborator was "AbbVie" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Medical University Innsbruck" with 2 trials as a collaborator, "Medical University of Vienna" with 2 trials as a collaborator and "Wilhelminenspital Vienna" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Wilhelminenspital" are "Multiple Myeloma" (10 trials), "Coronary Artery Disease" (4 trials), "Atrial Fibrillation" (3 trials), "Hepatitis C, Chronic" (3 trials) and "Abdominal Aortic Aneurysm" (2 trials). Many other conditions were trialed in "Wilhelminenspital" in a lesser frequency.

Most popular intervention types in "Wilhelminenspital" are "Drug" (45 trials), "Device" (18 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (7 trials), "Placebo" (5 trials), "Thalidomide" (3 trials), "Aspirin" (2 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wilhelminenspital" are 74 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Wilhelminenspital". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Wilhelminenspital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Wilhelminenspital, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 14 trials that are defined as “Not Applicable".